FOR IMMEDIATE RELEASE
London, 22 April 2013
Annual Report and Accounts
Notice of Annual General Meeting: 23 May 2013
ImmuPharma PLC (AIM:IMM) (the "Company") the specialist drug discovery and development company, confirms that the Annual Report and Accounts for the year ended 31 December 2012 has been posted to shareholders.
The Annual Report is available, in electronic form, for download on the Company's website www.immupharma.com.
The Company's Annual General Meeting will be held on 23 May 2013 at 11:00am at the offices of Bircham Dyson Bell LLP, 50 Broadway, London, SW1H 0BL.
For further information please contact:
ImmuPharma PLC
Richard Warr, Chairman +44 20 7152 4080
Dimitri Dimitriou, Chief Executive Officer +44 20 7152 4080
Lisa Baderoon, Head of Investor Relations +44 7721 413 496
Panmure Gordon & Co., NOMAD & Broker +44 20 7886 2500
Hugh Morgan, Fred Walsh, Hannah Woodley
This information is provided by RNS